Pharma Capital

Realm Therapeutics CEO Alex Martin presents to investors at the Biotech Capital Conference

Realm Therapeutics CEO Alex Martin presents to investors at the Biotech Capital Conference

 
Sarah_55b0a64c2a6b3.jpg

View full RLM profile

Realm Therapeutics plc Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.